Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Fraile

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Metabolic syndrome characteristics in gout patientsJ M Fraile, R J Torres, Mendieta E de Miguel, et al.
Gastroenterologia Y Hepatologia|June 20, 1998
[Chronic cholestasis as a presentation form of portal cavernoma]M D García Escaño, R J Andrade, R Alcántara, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2002
Improvement of ligand economy controlled by polymer morphology: the case of polymer-supported bis(oxazoline) catalystsM I Burguete, E Díez-Barra, J M Fraile, et al.
Biomaterials Science|October 5, 2020
Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal modelM J Rodrigo, M J Cardiel, J M Fraile, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Metabolic syndrome characteristics in gout patientsJ M Fraile, R J Torres, Mendieta E de Miguel, et al.
Gastroenterologia Y Hepatologia|June 20, 1998
[Chronic cholestasis as a presentation form of portal cavernoma]M D García Escaño, R J Andrade, R Alcántara, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2002
Improvement of ligand economy controlled by polymer morphology: the case of polymer-supported bis(oxazoline) catalystsM I Burguete, E Díez-Barra, J M Fraile, et al.
Biomaterials Science|October 5, 2020
Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal modelM J Rodrigo, M J Cardiel, J M Fraile, et al.
Pageof 2